Steatotic Liver Disease, Sarcopenia, and Fibrosis Linked to Higher Mortality Risk: 15.7-Year Study Findings Medha Baranwal19 Feb 2025 8:30 PM ISTChina: A recent cohort study spanning 15.7 years has highlighted the significant impact of steatotic liver disease (SLD) subtypes, sarcopenia, and...
Metabolic dysfunction-associated fatty liver disease an independent predictor of CKD: Study Dr.Niharika Harsha B2 Jan 2025 12:45 AM ISTA groundbreaking study published in BMC Nephrology found that metabolic dysfunction associated fatty liver disease (MAFLD) was an independent...
MAFLD tied to hyperfiltration and amplification of age-related eGFR decline across all glycaemic spectrum: Study Dr Kartikeya Kohli28 May 2024 9:00 AM ISTSpain: In a pioneering cross-sectional population study, researchers have uncovered a significant association between Metabolic Associated Fatty Liver...
Metabolic dysfunction-associated fatty liver disease may increase risk of gallstone development: JAMA Medha Baranwal6 Feb 2024 9:30 AM ISTJapan: Findings from a recent longitudinal study have revealed a significant association between metabolic dysfunction-associated fatty liver disease...
Heavy Metal Exposure linked to Metabolic Dysfunction-Associated Fatty Liver Disease Risk Jacinthlyn Sylvia1 Jan 2024 2:00 AM ISTA recent study by Yuguang Li and team unveiled the critical association between heavy metal exposure and the occurrence of Metabolic...
MAFLD increases risk of mortality independent of excessive alcohol consumption Jacinthlyn Sylvia23 March 2023 10:00 AM ISTMetabolic dysfunction-associated fatty liver disease (MAFLD) raises the risk of death independently of excessive alcohol use, says an article...
SGLT2 inhibitors improve FIB-4 index better than pioglitazone in MAFLD patients Aditi20 March 2023 10:30 AM ISTJapan: A study entitled "Effects of sodium-glucose cotransporter two inhibitors and pioglitazone on FIB-4 index in metabolic associated fatty liver...
Glycated albumin and HbA1C ratio simple and practical indicator of MAFLD risk in diabetes Aditi25 Nov 2022 8:00 PM ISTA study published in Diabetology & Metabolic Syndrome, BMC, has concluded that in Type 2 Diabetes Mellitus patients, the glycated albumin/HbA1C...
Gastric Bypass improves Metabolic Dysfunction-Associated Fatty Liver Disease in Low-BMI Patients Dr.Niharika Harsha B11 Oct 2022 9:30 AM ISTA new study found that Roux-en-Y gastric bypass therapy showed good results in patients having low-body mass index with insulin-treated type 2...
